IntroductionThe respiratory drugs market refers to the segment of the pharmaceutical industry that deals with drugs designed to treat respiratory disorders, including asthma, chronic obstructive ...

Young man using medicine dry powder inhaler for treatment asthma or COPD diseases. Pharmaceutical product is used to treat ...

Last year, the FDA approved the biologic drug Dupixent to treat uncontrolled eosinophilic COPD. The approval marked a step ...

SIGNIFICANT EVENTS DURING 1 JANUARY - 31 MARCH 2025Iconovo and Lonza have entered a collaboration to develop spray-dried formulations of an intranasal biologic drug for Iconovo's proprietary intranasa ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...

Pressurized metered-dose inhalers (pMDIs) for COPD and asthma contribute to climate change, and countries are moving away from their use.

The global aerosol delivery devices market was valued at $31,463.9 million in 2019, and is projected to reach $46,728.7 million by 2027, registering a CAGR of 4.9% from 2020 to 2027. Rise in ...

Patients could see their lives transformed with a new treatment plan that changes when they take their medication, experts have revealed.

An afternoon dose also yielded significantly better overnight (10 p.m. to 4 a.m.) suppression in blood eosinophil counts as a marker of airway inflammation compared with the other two groups, although ...

Researchers from Keele University have said there are multiple barriers preventing clinicians from prescribing alternative treatments for asthma patients, despite guidance calling for a move toward ...